Grant Funding
Gilead Sciences funds nonprofit-led, high-impact projects advancing research, education, and health equity in HIV, liver disease, oncology, and chronic inflammatory diseases.
Funder: Gilead Sciences
Due Dates: Rolling (applications accepted year-round; submit at least 6 weeks before project start)
Funding Amounts: No set minimum or maximum; funding is for up to one year per project, request what is needed for project success.
Summary: Supports innovative, data-driven healthcare projects in HIV, liver disease, oncology, and chronic inflammatory diseases, with a focus on community support and health equity.
Key Information: Only nonprofit organizations are eligible; no retroactive funding; must submit detailed project budget.
Description
Gilead Sciences offers grant funding to nonprofit organizations worldwide for projects that strengthen healthcare infrastructure, provide education, and support vulnerable communities. The program prioritizes measurable, high-impact initiatives in Gilead’s core therapeutic areas: HIV, liver diseases (including hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and chronic inflammatory diseases. Funding is also available for community support activities such as educational events, resource development, patient advocacy, and health equity initiatives. Gilead works with a broad range of organizations including hospitals, academic centers, professional associations, and patient advocacy groups.
